When a human single cell is crippled (Deranged DNA) with mixed up molecular behavior that is the initiator of the problem. A once normal cell now transitioned into full threatening molecular time bomb. In the modeling and creation of a tumor it all begins with the singular molecular crisis an...
During the period between9/2015 and 6/2017the Team atLeaders in Pharmaceutical Business Intelligence (LPBI)has launched anR&D effortlead byAviva Lev-Ari, PhD, RNin conjunction withSBH Sciences, Inc.headed byDr. Raphael Nir. This effort, also known as,“DrugDiscovery @LPBI Group”has yielded ...
There was a woman who came and it was really a hard time with her, but we knew that she, she learned to play the piano. And then when we came to pick her up, she did not want to come out of the room. And we said to her, it would be good if you come to eat with the ot...
Medicine with GPT-4 & ChatGPT Grok, DeepSeek & Expert Models in HealthcareLeaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, me...
Image Source:Leaders in Pharmaceutical Business Intelligence (LPBI) Group Aviva Lev-Ari, PhD, RNwill be in attendance covering the event in REAL TIME @pharma_BI @AVIVA1950 #IESYMPOSIUM @KOCHINSTITUTE The Immune System, Stress Signaling, Infectious Diseases and Therapeutic Implications: VOLUME 2: ...
“The efficiency and ease of use is completely unprecedented. I’m jumping out of my skin with excitement,” saidGeorge Church, a geneticist at Harvard University who led one of the teams that used Crispr to edit the human genome for the first time. ...
Targeting hematopoietic stem cells Larry H. Bernstein, MD, FCAP, Curator LPBI New technology uncovered the stem cell niche in the bone marrow Hematopoietic stem cells (HSCs) are so rare that it's difficult to comprehensively localize dividing and non-d